Jesse Shefferman - 16 Jan 2026 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)

Role
CEO and President, Director
Signature
/s/ Jesse Shefferman
Issuer symbol
TARA
Transactions as of
16 Jan 2026
Net transactions value
$0
Form type
4
Filing time
21 Jan 2026, 16:36:25 UTC
Previous filing
30 Jun 2025
Next filing
22 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Shefferman Jesse CEO and President, Director C/O PROTARA THERAPEUTICS, INC., 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK /s/ Jesse Shefferman 21 Jan 2026 0001799167

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARA Common Stock Award $0 +87,000 +9.1% $0.000000 1,046,886 16 Jan 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TARA Stock Option (Right to Buy) Award $0 +524,000 $0.000000 524,000 16 Jan 2026 Common Stock 524,000 $5.01 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 16, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such date.
F2 25% of the shares vest on the one year anniversary of January 16, 2026 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.